Joint degeneration affects over 80% of seniors. While mainstream medicine attributes this to "wear and tear", recent findings reveal a hidden culprit: the drying up of synovial fluid (the body's natural lubricant) due to poor blood flow in avascular cartilage.
This article presents evidence on how a new Transdermal Nanoparticle Protocol bypasses the digestive system to deliver lubrication directly to the joint capsule, reversing stiffness and pain without surgery.
Most patients believe their pain is due to bones rubbing together. This assumption is partially correct, but the cause is incorrect. The true cause is Synovial Fluid Depletion.
Just like an engine seizes without oil, joints seize without synovial fluid. Because joint cartilage is avascular (lacks blood vessels), oral pills (Glucosamine) cannot reach the target area effectively. They are destroyed by stomach acid before they can help.
Studies from Johns Hopkins confirm that oral joint supplements have a bioavailability of less than 8% in the knee joint. This explains why pills fail for most seniors.
However, new research shows that the skin over joints is highly permeable to specific lipid-carriers, allowing for direct "Transdermal Feeding" of the joint tissue.
Researchers adapted a transdermal technology used in aerospace medicine. By using nanoparticle carriers, they could deliver high concentrations of soothing agents directly through the skin barrier (stratum corneum) into the synovial cavity.
The cumulative evidence shows that transdermal delivery is superior to oral supplementation for joint pain. The Arthrovix+ formulation replicates this clinical protocol for public use.
Access the Official Clinical Formula Here >
Due to high demand, supply is limited on a first-come, first-served basis.